C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 9/22 (2006.01) A61K 38/00 (2006.01) A61K 39/395 (2006.01) A61M 1/36 (2006.01) C07K 1/107 (2006.01) C07K 1/22 (2006.01) C07K 2/00 (2006.01) C07K 16/00 (2006.01) C07K 16/18 (2006.01) C07K 16/44 (2006.01) G01N 33/543 (2006.01) G01N 33/573 (2006.01) G01N 33/66 (2006.01) G01N 33/68 (2006.01) G01N 33/72 (2006.01)
Patent
CA 2126209
2126209 9313421 PCTABS00024 The circulating advanced glycosylation endproducts Hb-AGE, serum AGE-peptides and urinary AGE-peptides are disclosed as long term markers of diseases and dysfunctions having as a characteristic the presence of a measurable difference in AGE concentration. Diagnostic and therapeutic protocols taking advantage of the characteristics of these AGEs are disclosed. Antibodies which recognize and bind to in vivo-derived advanced glycosylation endproducts are also disclosed. Methods of using these antibodies as well as pharmaceutical compositions are also disclosed, along with numerous diagnostic applications, including methods for the measurement of the presence and amount of advanced glycosylation endproducts in both plants and animals, including humans, as well as in cultivated and synthesized protein material for therapeutic use.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
The Rockefeller University
LandOfFree
Immunochemical detection of in vivo advanced glycosylation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunochemical detection of in vivo advanced glycosylation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunochemical detection of in vivo advanced glycosylation... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1956787